Diane J. Poole

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Ravi A. Madan, Mahsa Mohebtash, Philip M. Arlen et al. · The Lancet Oncology · 2012 · 327 citations · Full text

Medicine, Immunology, Oncology +17

Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancer

James L. Gulley, Philip M. Arlen, Ravi A. Madan et al. · Cancer Immunology Immunotherapy · 2009 · 298 citations · Full text

Medicine, Immunology, Oncology +17

Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma

James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang et al. · Clinical Cancer Research · 2008 · 229 citations · Full text

Medicine, Immunology, Oncology +17

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV‐PSA) in patients with metastatic androgen‐independent prostate cancer

James L. Gulley, Alice P. Chen, William L. Dahut et al. · The Prostate · 2002 · 226 citations · Full text

Veterinary Medicine, Immunology, Oncology +17

Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.

Raffaella Muraro, Manabu Kuroki, D. Wunderlich et al. · PubMed · 1988 · 209 citations

Medicine, Oncology, Pathology +17